BREZTRI AEROSPHERE
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $1.5M | 21,801 | 13,029 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $584,625 | 513 | 39.0% |
| Food and Beverage | $408,487 | 19,425 | 27.3% |
| Unspecified | $296,903 | 7 | 19.8% |
| Consulting Fee | $172,230 | 151 | 11.5% |
| Education | $20,162 | 1,554 | 1.3% |
| Travel and Lodging | $15,189 | 150 | 1.0% |
| Space rental or facility fees (teaching hospital only) | $750.00 | 1 | 0.1% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| PT010 Pearl Triple MDI Phase 3 Exacerbation Ethos PT010005 | AstraZeneca Pharmaceuticals LP | $283,388 | 0 |
| Onset of Effect Questionnaire | AstraZeneca Pharmaceuticals LP | $13,515 | 0 |
Top Doctors Receiving Payments for BREZTRI AEROSPHERE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Falls Church, VA | $297,653 | 8 |
| , M.D | Internal Medicine | Greensboro, NC | $29,060 | 38 |
| , MD | Critical Care Medicine | Anderson, IN | $26,880 | 26 |
| , M.D | Pulmonary Disease | Jackson, MS | $21,535 | 28 |
| , MD | Critical Care Medicine | Orlando, FL | $20,872 | 33 |
| , MD | Pulmonary Disease | Brighton, MA | $19,222 | 12 |
| , M.D | Internal Medicine | Farmington Hills, MI | $17,766 | 18 |
| , M.D | Internal Medicine | Sacramento, CA | $16,988 | 19 |
| , MD | Internal Medicine | Terre Haute, IN | $15,520 | 26 |
| , DO | Pulmonary Disease | Mesa, AZ | $14,175 | 20 |
| , M.D | Pulmonary Disease | Chicago, IL | $13,358 | 11 |
| , M.D | Pulmonary Disease | Washington, MO | $12,997 | 15 |
| , MD | Critical Care Medicine | Kissimmee, FL | $12,886 | 23 |
| , M.D | Pulmonary Disease | Chester, PA | $12,649 | 18 |
| , M.D | Pulmonary Disease | Claremont, NH | $11,551 | 9 |
| , MD | Pulmonary Disease | San Antonio, TX | $11,058 | 9 |
| , M.D | Pulmonary Disease | Affton, MO | $10,853 | 15 |
| , M.D | Family Medicine | Jenkintown, PA | $10,200 | 8 |
| , MD | Internal Medicine | Williamsville, NY | $9,725 | 7 |
| , M.D | Pulmonary Disease | Kansas City, MO | $9,485 | 17 |
| , MD | Pulmonary Disease | Louisville, KY | $9,429 | 14 |
| , M.D | Critical Care Medicine | Charlottesville, VA | $9,216 | 13 |
| , MD | Pulmonary Disease | Wethersfield, CT | $9,087 | 12 |
| , M.D | Student in an Organized Health Care Education/Training Program | Breese, IL | $9,069 | 17 |
| , MD | Pulmonary Disease | Fort Pierce, FL | $9,014 | 11 |
Manufacturing Companies
- AstraZeneca Pharmaceuticals LP $1.5M
- AstraZeneca UK Limited $3,594
Product Information
- Type Drug
- Total Payments $1.5M
- Total Doctors 13,029
- Transactions 21,801
About BREZTRI AEROSPHERE
BREZTRI AEROSPHERE is a drug associated with $1.5M in payments to 13,029 healthcare providers, recorded across 21,801 transactions in the CMS Open Payments database. The primary manufacturer is AstraZeneca Pharmaceuticals LP.
Payment data is available from 2020 to 2020. In 2020, $1.5M was paid across 21,801 transactions to 13,029 doctors.
The most common payment nature for BREZTRI AEROSPHERE is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($584,625, 39.0% of total).
BREZTRI AEROSPHERE is associated with 2 research studies, including "PT010 Pearl Triple MDI Phase 3 Exacerbation Ethos PT010005" ($283,388).